346 related articles for article (PubMed ID: 23093485)
1. Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.
Harrer A; Tumani H; Niendorf S; Lauda F; Geis C; Weishaupt A; Kleinschnitz C; Rauer S; Kuhle J; Stangel M; Weber F; Uhr M; Linnebank M; Wildemann B; Jarius S; Guger M; Ayzenberg I; Chan A; Zettl U; Wiendl H; Pilz G; Hitzl W; Weber JR; Kraus J
Mult Scler; 2013 Aug; 19(9):1209-12. PubMed ID: 23093485
[TBL] [Abstract][Full Text] [Related]
2. Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: a longitudinal study.
Mancuso R; Franciotta D; Rovaris M; Caputo D; Sala A; Hernis A; Agostini S; Calvo M; Clerici M
Mult Scler; 2014 Dec; 20(14):1900-3. PubMed ID: 24948690
[TBL] [Abstract][Full Text] [Related]
3. Disappearance of cerebrospinal fluid oligoclonal bands after natalizumab treatment of multiple sclerosis patients.
von Glehn F; Farias AS; de Oliveira AC; Damasceno A; Longhini AL; Oliveira EC; Damasceno BP; Santos LM; Brandão CO
Mult Scler; 2012 Jul; 18(7):1038-41. PubMed ID: 22041091
[TBL] [Abstract][Full Text] [Related]
4. Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.
Warnke C; Stettner M; Lehmensiek V; Dehmel T; Mausberg AK; von Geldern G; Gold R; Kümpfel T; Hohlfeld R; Mäurer M; Stangel M; Straeten V; Limmroth V; Weber T; Kleinschnitz C; Wattjes MP; Svenningsson A; Olsson T; Hartung HP; Hermsen D; Tumani H; Adams O; Kieseier BC
Mult Scler; 2015 Jul; 21(8):1036-44. PubMed ID: 25392339
[TBL] [Abstract][Full Text] [Related]
5. Elevated antibody reactivity to measles virus NCORE protein among patients with multiple sclerosis and their healthy siblings with intrathecal oligoclonal immunoglobulin G production.
Persson L; Longhi S; Enarsson J; Andersen O; Haghigi S; Nilsson S; Lagging M; Johansson M; Bergström T
J Clin Virol; 2014 Sep; 61(1):107-12. PubMed ID: 25022622
[TBL] [Abstract][Full Text] [Related]
6. Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab.
Villar LM; Costa-Frossard L; Masterman T; Fernandez O; Montalban X; Casanova B; Izquierdo G; Coret F; Tumani H; Saiz A; Arroyo R; Fink K; Leyva L; Espejo C; Simó-Castelló M; García-Sánchez MI; Lauda F; Llufriú S; Álvarez-Lafuente R; Olascoaga J; Prada A; Oterino A; de Andrés C; Tintoré M; Ramió-Torrentà L; Rodríguez-Martín E; Picón C; Comabella M; Quintana E; Agüera E; Díaz S; Fernandez-Bolaños R; García-Merino JA; Landete L; Menéndez-González M; Navarro L; Pérez D; Sánchez-López F; Serrano-Castro PJ; Tuñón A; Espiño M; Muriel A; Bar-Or A; Álvarez-Cermeño JC
Ann Neurol; 2015 Mar; 77(3):447-57. PubMed ID: 25581547
[TBL] [Abstract][Full Text] [Related]
7. The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.
Beseler C; Vollmer T; Graner M; Yu X
PLoS One; 2017; 12(10):e0186842. PubMed ID: 29059249
[TBL] [Abstract][Full Text] [Related]
8. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
Link H; Huang YM
J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
[TBL] [Abstract][Full Text] [Related]
9. Baló's concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures.
Jarius S; Würthwein C; Behrens JR; Wanner J; Haas J; Paul F; Wildemann B
J Neuroinflammation; 2018 Jan; 15(1):22. PubMed ID: 29347989
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of cerebrospinal fluid oligoclonal IgG bands in Greek patients with clinically isolated syndrome and multiple sclerosis.
Andreadou E; Chatzipanagiotou S; Constantinides VC; Rombos A; Stamboulis E; Nicolaou C
Clin Neurol Neurosurg; 2013 Oct; 115(10):2094-8. PubMed ID: 23953642
[TBL] [Abstract][Full Text] [Related]
11. MS and clinically isolated syndromes: shared specificity but diverging clonal patterns of virus-specific IgG antibodies produced in vivo and by CSF B cells in vitro.
Skorstad G; Vandvik B; Vartdal F; Holmøy T
Eur J Neurol; 2009 Oct; 16(10):1124-9. PubMed ID: 19469834
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal human herpesvirus 6 antibodies in multiple sclerosis and other demyelinating diseases presenting as oligoclonal bands in cerebrospinal fluid.
Virtanen JO; Pietiläinen-Nicklén J; Uotila L; Färkkilä M; Vaheri A; Koskiniemi M
J Neuroimmunol; 2011 Aug; 237(1-2):93-7. PubMed ID: 21767883
[TBL] [Abstract][Full Text] [Related]
13. Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.
Stüve O; Marra CM; Bar-Or A; Niino M; Cravens PD; Cepok S; Frohman EM; Phillips JT; Arendt G; Jerome KR; Cook L; Grand'Maison F; Hemmer B; Monson NL; Racke MK
Arch Neurol; 2006 Oct; 63(10):1383-7. PubMed ID: 17030653
[TBL] [Abstract][Full Text] [Related]
14. Immunological markers of optimal response to natalizumab in multiple sclerosis.
Villar LM; García-Sánchez MI; Costa-Frossard L; Espiño M; Roldán E; Páramo D; Lucas M; Izquierdo G; Álvarez-Cermeño JC
Arch Neurol; 2012 Feb; 69(2):191-7. PubMed ID: 22332187
[TBL] [Abstract][Full Text] [Related]
15. Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.
Lourenco P; Shirani A; Saeedi J; Oger J; Schreiber WE; Tremlett H
Mult Scler; 2013 Apr; 19(5):577-84. PubMed ID: 22961214
[TBL] [Abstract][Full Text] [Related]
16. The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis.
Axelsson M; Mattsson N; Malmeström C; Zetterberg H; Lycke J
J Neuroimmunol; 2013 Nov; 264(1-2):100-5. PubMed ID: 24125567
[TBL] [Abstract][Full Text] [Related]
17. Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerebrospinal fluid.
Reiber H; Teut M; Pohl D; Rostasy KM; Hanefeld F
Mult Scler; 2009 Dec; 15(12):1466-80. PubMed ID: 19995844
[TBL] [Abstract][Full Text] [Related]
18. Oligoclonal restriction of antiviral immunoreaction in oligoclonal band-negative MS patients.
Stich O; Kluge J; Speck J; Rauer S
Acta Neurol Scand; 2015 Jun; 131(6):381-8. PubMed ID: 25402869
[TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct.
Imrell K; Landtblom AM; Hillert J; Masterman T
Neurology; 2006 Sep; 67(6):1062-4. PubMed ID: 17000979
[TBL] [Abstract][Full Text] [Related]
20. MRZH reaction increases sensitivity for intrathecal IgG synthesis in IgG Oligoclonal band negative Multiple Sclerosis patients.
Dias-Carneiro RP; von Glehn F; Moraes AS; Boldrini VO; Damasceno A; Andrade MD; Lima AC; Casanova CS; Tilbery CP; Damasceno BP; Santos LM; Brandão CO
J Neuroimmunol; 2016 Nov; 300():30-35. PubMed ID: 27806873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
